IART
USDIntegra LifeSciences Holdings Corporation Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$11.390
Kõrge
$11.600
Madal
$11.220
Maht
0.19M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
880.2M
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
1.22M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.